Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory
- PMID: 28923013
- PMCID: PMC5604499
- DOI: 10.1186/s12874-017-0420-7
Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory
Abstract
Background: The clinical research enterprise is not producing the evidence decision makers arguably need in a timely and cost effective manner; research currently involves the use of labor-intensive parallel systems that are separate from clinical care. The emergence of pragmatic clinical trials (PCTs) poses a possible solution: these large-scale trials are embedded within routine clinical care and often involve cluster randomization of hospitals, clinics, primary care providers, etc. Interventions can be implemented by health system personnel through usual communication channels and quality improvement infrastructure, and data collected as part of routine clinical care. However, experience with these trials is nascent and best practices regarding design operational, analytic, and reporting methodologies are undeveloped.
Methods: To strengthen the national capacity to implement cost-effective, large-scale PCTs, the Common Fund of the National Institutes of Health created the Health Care Systems Research Collaboratory (Collaboratory) to support the design, execution, and dissemination of a series of demonstration projects using a pragmatic research design.
Results: In this article, we will describe the Collaboratory, highlight some of the challenges encountered and solutions developed thus far, and discuss remaining barriers and opportunities for large-scale evidence generation using PCTs.
Conclusion: A planning phase is critical, and even with careful planning, new challenges arise during execution; comparisons between arms can be complicated by unanticipated changes. Early and ongoing engagement with both health care system leaders and front-line clinicians is critical for success. There is also marked uncertainty when applying existing ethical and regulatory frameworks to PCTS, and using existing electronic health records for data capture adds complexity.
Keywords: Cluster randomized trials; Embedded clinical trials; Pragmatic clinical research; Pragmatic research; Stakeholder engagement.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable. We are not reporting patient data.
Consent for publication
Not applicable.
Competing interests
Dr. Coronado served as a co-Investigator on a study, Adherence to Minimally Invasive CRC Screening in Patients Who Have Not Completed CRC Screening (ADMIT) 11/14–08/15, funded by Epigenomics.
Dr. Jarvik was a consultant for HealthHelp, a radiology benefits management company. He currently is a section editor for UpToDate.
Dr. Mor holds stock of unknown value in PointRight, Inc. an information services company providing advice and consultation to the long-term care and post-acute care industry; he chairs the Independent Quality Committee for HRC Manor Care, Inc., a nursing home chain and chairs the Scientific Advisory Committee for NaviHealth, a post-acute care service organization.
Dr. Huang conducted clinical trials and studies in which participating hospitals and nursing homes received contributed antiseptic products from Sage Products, Molnlycke, 3 M, Clorox, and Xttrium. The ABATE Infection Trial hospitals received antiseptic products from Sage Products and Molnlycke. All companies that contributed product had no role in the design, conduct, analysis, or publication of these studies.
Dr. Platt has research support from Clorox Corporation.
Dr. Septimus for the ABATE Infection Trial hospitals received antiseptic products from Sage Products and Molnlycke. All companies that contributed product had no role in the design, conduct, analysis, or publication of these studies.
Authors not named here have disclosed no conflicts of interest.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
-
- Feuerstein JD, Akbari M, Gifford AE, Hurley CM, Leffler DA, Sheth SG, et al. Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in interventional medicine subspecialty guidelines. Mayo Clin Proc. 2014;89:16–24. doi: 10.1016/j.mayocp.2013.09.013. - DOI - PubMed
MeSH terms
Grants and funding
- UH2 AT007769/AT/NCCIH NIH HHS/United States
- UH3 CA188640/CA/NCI NIH HHS/United States
- UH2 MH106338/MH/NIMH NIH HHS/United States
- UH2 DK104655/DK/NIDDK NIH HHS/United States
- UH3 AI113337/AI/NIAID NIH HHS/United States
- UH2 AT007766/AT/NCCIH NIH HHS/United States
- UH2 AG049619/AG/NIA NIH HHS/United States
- UH3 DK104655/DK/NIDDK NIH HHS/United States
- UH3 AR066795/AR/NIAMS NIH HHS/United States
- UH3 MH106338/MH/NIMH NIH HHS/United States
- UH2 AT007788/AT/NCCIH NIH HHS/United States
- UH2 AT007797/AT/NCCIH NIH HHS/United States
- UH2 AT007782/AT/NCCIH NIH HHS/United States
- U54 AT007748/AT/NCCIH NIH HHS/United States
- UH3 DK102384/DK/NIDDK NIH HHS/United States
- UH2 AT007784/AT/NCCIH NIH HHS/United States
- UH2 AT007755/AT/NCCIH NIH HHS/United States
- UH3 NS088731/NS/NINDS NIH HHS/United States
- UH3 AG049619/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical